Stock comparison
United Therapeutics
UTHR$24.13BHealthcare Market cap, Sector
Veeva Systems
VEEV$26.07BHealthcare Market cap, Sector
Overall winner
Veeva Systems
UTHR 34 VEEV
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
UTHR3wins
4winsVEEV
71B
C66
76B
B81
76B
B77
62C
C60
46D
D52
64C
C62
64C
C65
Side-by-side metrics
| Metric | UTHR | VEEV |
|---|---|---|
| Market cap | $24.13B | $26.07B Winner |
| P/E (TTM) | Winner: 19.2x | 28.7x |
| EV/EBIT | Winner: 15.2x | 26.9x |
| ROIC (TTM) | Winner: 18.81% | 9.48% |
| Gross margin | Winner: 86.58% | 75.53% |
| Net margin | Winner: 40.61% | 28.44% |
| Revenue CAGR 5y | Winner: 17.22% | 14.63% |
| EPS CAGR 5y | Winner: 29.84% | 18.76% |
| Debt / Equity | Winner: - | 0.0x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
UTHR leads on
- Debt / Equity-vs 0.0x+100%
- ROIC (TTM)18.81%vs 9.48%+50%
- EV/EBIT15.2xvs 26.9x+43%
- EPS CAGR 5y29.84%vs 18.76%+37%
VEEV leads on
- Market cap$26.07Bvs $24.13B+7%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.